1st Quarter - Report
FOLEY & LARDNER LLP for AOVA TECHNOLOGIES
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Funding for vaccine research and development, mass antibody production and alternatives to antibiotics in animal feed
| Lobbyist | Covered position, as disclosed |
|---|---|
| THEODORE H BORNSTEIN | COS Rep. Aspin; COS Sen. Kohl; OSD-DOD |
| JOSEPH L COLANERI New | — |
| ROBERT C GEIST New | Press for Rep. Porter Goss, Rep. Frank LoBiondo |
| SCOTT L KLUG | Member of Congress 1990-1998 |
Defense DEF
Funding for vaccine research and development, mass antibody production and alternatives to antibiotics in animal feed
| Lobbyist | Covered position, as disclosed |
|---|---|
| THEODORE H BORNSTEIN | COS Rep. Aspin; COS Sen. Kohl; OSD-DOD |
| JOSEPH L COLANERI New | — |
| ROBERT C GEIST New | Press for Rep. Porter Goss, Rep. Frank LoBiondo |
| SCOTT L KLUG | Member of Congress 1990-1998 |
Agriculture AGR
Funding for vaccine research and development, mass antibody production and alternatives to antibiotics in animal feed
| Lobbyist | Covered position, as disclosed |
|---|---|
| THEODORE H BORNSTEIN | COS Rep. Aspin; COS Sen. Kohl; OSD-DOD |
| JOSEPH L COLANERI New | — |
| ROBERT C GEIST New | Press for Rep. Porter Goss, Rep. Frank LoBiondo |
| SCOTT L KLUG | Member of Congress 1990-1998 |
Homeland Security HOM
Funding for vaccine research and development, mass antibody production and alternatives to antibiotics in animal feed
| Lobbyist | Covered position, as disclosed |
|---|---|
| THEODORE H BORNSTEIN | COS Rep. Aspin; COS Sen. Kohl; OSD-DOD |
| JOSEPH L COLANERI New | — |
| ROBERT C GEIST New | Press for Rep. Porter Goss, Rep. Frank LoBiondo |
| SCOTT L KLUG | Member of Congress 1990-1998 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.